Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty500 Healthcare Index
Nifty500 Healthcare Index Performance
Low
₹21,100.65
High
₹21,474.40
52 Week Range
Low
₹17,164.05
High
₹22,125.15
| Previous Close | ₹21,130.15 |
|---|---|
| Day's Range | ₹21,100.65 - ₹21,474.40 |
| Open | ₹21,142.20 |
| 52 Week Range | ₹17,164.05 - ₹22,125.15 |
| Volume | 4,93,57,679 |
Nifty500 Healthcare Index Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1374.30 |  16.30 (1.20%) |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1359.10 | 14.10 (1.05%) |
Healthcare |
| Lupin Ltd. | 2017.40 | 27.50 (1.38%) |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 4643.50 | 63.50 (1.39%) |
Healthcare |
| Abbott India Ltd. | 26080.00 |  -65.00 (-0.25%) |
Healthcare |
| Glaxosmithkline Pharmaceuticals Ltd. | 2521.40 | 6.30 (0.25%) |
Healthcare |
| Apollo Hospitals Enterprise Ltd. | 8311.00 | 111.00 (1.35%) |
Healthcare |
| Ipca Laboratories Ltd. | 1929.90 | 3.70 (0.19%) |
Healthcare |
| Neuland Laboratories Ltd. | 19500.00 | 220.00 (1.14%) |
Healthcare |
| Sun Pharmaceutical Industries Ltd. | 1809.10 | 48.10 (2.73%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23086.4 | 26373.20 | 22179.90 |
| Nifty IT | 32566.35 | 40301.40 | 25699.10 |
| Nifty Next 50 | 67872.45 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8406.45 | 10443.40 | 7839.85 |
| Nifty Bank | 54936.45 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 57523.15 | 64450.90 | 52032.85 |
| Nifty 500 | 21952.25 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 16568.25 | 18500.95 | 14804.55 |
| Nifty 100 | 24009.9 | 26975.15 | 22720.45 |
| Nifty FMCG | 43596.95 | 56756.15 | 42006.00 |
Latest News
Rubicon Research informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Rubicon Research has informed that the United States Food and Drug Administration (US FDA) conducted an unannounced inspection (triggered by a product filing) of the company’s manufacturing facility located at Plot No. K30/4 & 30/5, Additional M.I.D.C., Anand Nagar, Ambernath, Maharashtra, India from Wednesday, 21 October 2026 to Thursday, 29 October 2026. This was a comprehensive GMP inspection in addition to the product application under review. Upon conclusion, a Form 483 containing 3 observations with respect to system improvement and 2 observations with respect to product application under review were issued, all 5 of which are procedural in nature and do not relate to data integrity. The company is confident of working closely with the regulator to successfully conclude the evaluation in a timely manner. All its manufacturing as well as R&D facilities have now been inspected by the US FDA in the recent past and it has enclosed the status of all its operational facilities.
Biocon informs about press release
Cipla informs about change in directorate
Cipla informs about grant of stock option
Sun Pharmaceutical Industries informs about allotment of NCDs
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of NFT500HEALTH index is ₹21460.3 as of 2026-10-30.
The total volume of NFT500HEALTH index is 49357679.00 as of 2026-10-30.
The percentage change in value of NFT500HEALTH index is 1.56% as of 2026-10-30.
The absolute increase in NFT500HEALTH index value since the previous trading day is ₹330.15 as of 2026-10-30.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
People Also Ask
The Nifty 500 Healthcare Index is a sectoral index that tracks selected healthcare companies from the Nifty 500 universe. It represents listed businesses across healthcare delivery, pharmaceuticals, diagnostics, biotechnology, medical services, and related segments.
Companies are selected from healthcare-sector stocks within the Nifty 500 universe based on NSE Indices' methodology and industry classification. The index is reviewed periodically in accordance with the index maintenance methodology.
The Nifty 500 Healthcare Index is calculated using the free-float market capitalisation method. This approach considers only publicly available shares while assigning weights to eligible healthcare companies within the index.
The Nifty 500 Healthcare Index includes companies from pharmaceuticals, hospitals, diagnostics, biotechnology, healthcare services, medical equipment, and related healthcare businesses listed within the broader Nifty 500 universe.
Yes, hospitals, diagnostics, and pharmaceutical companies may be part of the Nifty 500 Healthcare Index if they meet the index provider’s eligibility rules. The index is designed to capture different areas of India’s healthcare sector.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
